title: Pregabalin in benzodiazepine withdrawal.
authors.forename: T
authors.initials: T
authors.lastname: Biermann
authors.forename: S
authors.initials: S
authors.lastname: Bleich
authors.forename: J
authors.initials: J
authors.lastname: Kornhuber
authors.forename: T
authors.initials: T
authors.lastname: Hillemacher
mesh_terms: D000328:Adult; D000525:Alprazolam / Q000009:adverse effects* / Q000627:therapeutic use; D000927:Anticonvulsants / Q000009:adverse effects / Q000627:therapeutic use*; D001008:Anxiety Disorders / Q000150:complications / Q000188:drug therapy / Q000523:psychology; D006801:Humans; D006993:Hypnotics and Sedatives / Q000009:adverse effects* / Q000627:therapeutic use; D008297:Male; D010698:Phobic Disorders / Q000150:complications / Q000188:drug therapy / Q000523:psychology; D000069583:Pregabalin; D013375:Substance Withdrawal Syndrome / Q000188:drug therapy* / Q000523:psychology; D005680:gamma-Aminobutyric Acid / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use
chemical_list: D000927:Anticonvulsants; D006993:Hypnotics and Sedatives; D000069583:Pregabalin; D005680:gamma-Aminobutyric Acid; D000525:Alprazolam